股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年9月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 碧生源控股有限公司 呈交日期: 2025年10月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00926 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 150,000,000 | USD | 0.0003333332 | USD | | 49,999.98 | | 增加 / 減少 (-) | | | 0 | | | USD | | 0 | | 本月底結存 | | | 150,000,000 | USD | 0.0003333332 | USD | | 49,999.98 | 本月底法定/註冊股本總額： ...

New Stock Activities - Companies currently in the IPO process include Botai Cheliang, Xipuni, and Zijin Gold International [1] - Chery Automobile is at the pricing stage, while Different Group is set for its listing date [1] Earnings Announcements - JBB Builders and Chuangneng Group are scheduled to announce their earnings [1] Shareholder Meetings - Companies holding shareholder meetings include Xinhua Wencuan, Jiajin Investment International, and Everbright Securities [1] - Other companies with scheduled meetings are Jiajin Investment International, Huangdafukong, Liangqing Holdings, Youran Muye, and Jinshi Holdings Group [1] Trading Suspension and Resumption - Changhong Jiahua is set to resume trading [1] Dividend Distribution - Companies with upcoming dividend-related dates include Tian Ge Interactive (ex-dividend date), KLN (dividend payment date), COSCO Shipping Holdings (ex-dividend date), Anta Sports (dividend payment date), and Yisheng Biotechnology (dividend payment date) [1] - Other companies with dividend-related dates include Tai Hing Group (ex-dividend date), Longji Group (dividend payment date), Zhou Li Fu (ex-dividend date), and Junjie Group Holdings (ex-dividend date) [1]

Financial Performance - The company's revenue for the first half of 2025 was RMB 258.9 million, an increase of 1.8% compared to RMB 254.3 million in the same period of 2024[12]. - Gross profit for the first half of 2025 reached RMB 177.6 million, up 2.4% from RMB 173.4 million in the same period of 2024[12]. - The gross profit margin improved to 68.6%, a 0.4 percentage point increase from 68.2% in the same period of 2024[12]. - Operating expenses totaled RMB 164.6 million, a decrease of 2.8% from RMB 169.3 million in the same period of 2024[12]. - The total comprehensive income for the first half of 2025 was RMB 12.4 million, compared to RMB 8.5 million in the same period of 2024[12]. - Basic and diluted earnings per share for the first half of 2025 were RMB 0.1014, up from RMB 0.0639 in the same period of 2024[12]. - The total comprehensive income for the first half of 2025 was RMB 12.4 million, up 45.9% from RMB 8.5 million in the same period of 2024[13]. - Operating profit increased to RMB 15.682 million from RMB 11.655 million, representing a 34.5% year-over-year growth[71]. - Net profit for the period was RMB 12.402 million, compared to RMB 7.813 million in the previous year, marking a 58.5% increase[71]. - Cash flow from operating activities increased significantly to RMB 31,804,000 in the first half of 2025, up from RMB 12,354,000 in the same period of 2024, marking a growth of 157.5%[77]. Sales and Marketing - The company expanded its offline sales network to nearly 290,000 OTC pharmacies across 31 provinces and municipalities in China[5]. - The company operates 63 online stores across 18 e-commerce platforms, enhancing its market reach[5]. - The group launched 63 stores on 18 e-commerce platforms for the sale of its products, including four types of health teas and weight loss products[14]. - The brand achieved significant recognition during the JD 618 shopping festival, ranking among the top in the health category with its two star products, 常菁茶 and 纖纖茶[21]. - The group strategically rebooted its marketing efforts on the Xiaohongshu platform, targeting younger consumer demographics to boost brand awareness and sales[24]. - The company focuses on weight management with core products like 常菁茶 and 常潤茶, achieving stable growth and over 100 million monthly exposures for 奥利司他 through targeted marketing strategies[25]. - The live streaming duration for the official flagship store reaches 18 hours daily, resulting in significant sales increases, with 常菁茶 achieving over 1 million in monthly sales[26]. Research and Development - The company has received 25 health food approvals and holds 118 patents, including 22 invention patents[4]. - Collaborative research with Beijing Technology University has shown significant health benefits for core products, resulting in one academic publication and two patent applications[30]. - The R&D department has applied for three invention patents and three utility model patents in the first half of 2025, enhancing the company's intellectual property portfolio[32]. - The company has upgraded its products for the U.S. market, ensuring compliance with local regulations and consumer needs, laying the groundwork for market entry[29]. Financial Position - The company's cash and cash equivalents as of June 30, 2025, totaled RMB 178.1 million, up from RMB 147.8 million as of December 31, 2024[55]. - The asset-liability ratio as of June 30, 2025, was 17.6%, compared to 15.2% as of December 31, 2024[63]. - The group had no bank borrowings or asset pledges as of June 30, 2025, consistent with the previous year[56]. - Inventory as of June 30, 2025, totaled RMB 28.2 million, an increase from RMB 26.4 million as of December 31, 2024[57]. - The fair value of financial assets measured at fair value through profit or loss was RMB 78.3 million as of June 30, 2025, slightly down from RMB 79.4 million as of December 31, 2024[51]. - The net asset value of the fund in which the company invested was approximately RMB 95.9 million as of June 30, 2025, accounting for about 16.2% of the group's total assets[53]. Shareholder Information - The company proposed an interim dividend of HKD 0.15 per share for the six months ended June 30, 2025, compared to HKD 0.9 per share for the same period in 2024, indicating a decrease of 83.3%[126]. - The company’s major shareholders, Zhao Yihong and Gao Yan, each hold 51.51% of the issued shares, with 62,975,657 shares owned[138]. - The total number of shares issued as of June 30, 2025, is 122,265,585[143]. - The company's share option plan was approved on March 8, 2024, and is valid for ten years[145]. Corporate Governance - The company has complied with the corporate governance code, except for the separation of the roles of Chairman and CEO, which was previously held by the same individual[160][161]. - The Audit Committee consists of three independent non-executive directors and has reviewed the unaudited interim financial information for the six months ended June 30, 2025[163]. - The company appointed a new CEO, Feng Bing, in June 2025, while Zhao Yihong transitioned to the role of Chief Strategy Officer[161].

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 本月底法定/註冊股本總額： USD 49,999.98 FF301 | | | 致：香港交易及結算所有限公司 公司名稱: 碧生源控股有限公司 呈交日期: 2025年9月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00926 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 150,000,000 | USD | 0.0003333332 | USD | | 49,999.98 | | 增加 / 減少 (-) | | | 0 | | | USD | | 0 | | 本月底結存 | | | 150,000,000 | USD | 0.0003333332 | USD | | 49,999.98 | ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對 其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分 內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 碧生源控股有限公司 BESUNYEN HOLDINGS COMPANY LIMITED ( 於開曼群島註冊成立的有限公司 ) (股份代號：926) 於二零二五年八月二十五日舉行的 股東特別大會投票表決結果 碧生源控股有限公司(「本公司」)董事(「董事」)會(「董事會」)欣然宣佈，在本公 司於二零二五年八月二十五日舉行的股東特別大會(「股東特別大會」)上，載列於日 期為二零二五年八月八日的股東特別大會通告(「該通告」)內的建議決議案(「該決議 案」)，已由本公司股東以投票表決方式正式通過。有關該決議案的投票表決結果如 下： | 普通決議案 | 票數 | | | --- | --- | --- | | | (概約%) | | | | 贊成 | 反對 | | 誠如通告決議案所載，批准自本公司股份溢價賬中 | 62,708,199 | 0 | | 宣派及派發中期股息每股普通股0.15港元，以及其 | (100. ...

Dear Non-registered Holder(s) (Note) , BESUNYEN HOLDINGS COMPANY LIMITED (Incorporated in the Cayman Islands with limited liability) （於開曼群島註冊成立的有限公司） (Stock code 股份代號: 926) Besunyen Holdings Company Limited (the "Company") - Extraordinary General Meeting ("EGM") of the Company to be held on Monday, 25 August 2025 The EGM of the Company will be held virtually using online platform at http://meetings.computershare.com/Besunyen_EGM202508 (the "Online Platform") at 10:30 a.m. on Monday, 25 August 2025. Sharehol ...

You will be able to view the live video broadcast of the EGM, cast your votes on the resolutions in real time and submit questions to the Company. From 10:00 a.m. on Monday, 25 August 2025, you can log in to the Online Platform for the EGM by visiting the meeting website and entering the following details: BESUNYEN HOLDINGS COMPANY LIMITED (Incorporated in the Cayman Islands with limited liability) （於開曼群島註冊成立的有限公司） (Stock code 股份代號: 926) Dear Shareholder(s), 8 August 2025 Besunyen Holdings Company Limited ( ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本通告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本通告全部或任何 部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 BESUNYEN HOLDINGS COMPANY LIMITED 碧生源控股有限公司 （於開曼群島註冊成立的有限公司） 茲通告碧生源控股有限公司（「本公司」）謹訂於二零二五年八月二十五日（星期一）上 午十時三十分以電子方式舉行股東特別大會（「股東特別大會」），以進行下列事宜： 普通決議案 「動議謹此批准自本公司的股份溢價賬中宣派及派發中期股息每股普通股0.15港元 （「中期股息」），並謹此授權本公司任何一名董事（或如須加蓋公司印鑑，則授權本 公司任何兩名董事）按其全權酌情認為就上述各項而言屬必需、適宜、合適及權宜 者採取行動、進行事宜並簽立文件及契據。」 承董事會命 碧生源控股有限公司 （股份代號：926） 股東特別大會通告 – 1 – 附註： 1. 股 東 特 別 大 會 將 以 電 子 方 式 舉 行 。 登 記 股 東 將 可 到 訪 網 站 http://meetings.computersh ...

將於二零二五年八月二十五日（星期一）舉行之股東特別大會 （或其任何續會）之代表委任表格 碧生源控股有限公司 BESUNYEN HOLDINGS COMPANY LIMITED （於開曼群島註冊成立的有限公司） （股份代號：926） 日期 簽署 股本中每股面值0.0003333332美元股份（「股份」） 股 之登記持有人，茲委任本公司股東特別大會（「大會」）主席 （附註3） 或 地址為 （電郵地址） 擔任本人╱吾等受委代表，為及代表本人╱吾等出席本公司謹訂於二零二五年八月二十五日（星期一）上午十時 三十分以電子形式舉行之大會（或其任何續會），藉以考慮並酌情通過召開大會通告（「通告」）所載之決議案，並 在大會（或其任何續會）代表本人╱吾等按照以下指示以本人╱吾等名義就有關決議案投票 （附註4） ： | 誠如通告決議案所載，批准自本公司股份溢價賬中宣派及派發中期股 | | | | | | --- | --- | --- | --- | --- | | 普通決議案 息每股普通股0.15港元，以及其附帶的所有事宜。 | 贊成 | （附註4） | 反對 | （附註4） | 本人╱吾等 （附註1） 地址為 為碧生源控股有限 ...

BESUNYEN HOLDINGS COMPANY LIMITED 碧生源控股有限公司 閣下如已將名下的碧生源控股有限公司股份全部出售或轉讓，應立即將本通函連同隨附的 代表委任表格送交買主或承讓人，或經手出售或轉讓的銀行經理、持牌證券交易商或其他代 理商，以便轉交買主或承讓人。 閣下對本通函的任何內容或應採取的行動如有任何疑問，應諮詢 閣下的持牌證券交易商或 其他註冊證券機構、銀行經理、律師、專業會計師或其他專業顧問。 （於開曼群島註冊成立的有限公司） （股份代號：926） 此 乃 要 件 請 即 處 理 香港交易及結算所有限公司及香港聯合交易所有限公司對本通函的內容概不負責，對其準 確性或完整性亦不發表任何聲明，並明確表示概不就因本通函全部或任何部分內容而產生 或因倚賴該等內容而引致的任何損失承擔任何責任。 建議宣派及派發中期股息 及 股東特別大會通告 碧生源控股有限公司謹訂於二零二五年八月二十五日（星期一）上午十時三十分以電子方式 舉行股東特別大會，召開股東特別大會的通告載於本通函第7至9頁。 無論 閣下能否出席股東特別大會，務請按隨附的代表委任表格印列的指示填妥表格，盡快 但無論如何於股東特別大會或其任 ...